MSI has designed a new technique called backscattering interferometry (BSI) that is based on the principle that light slows down and scatters in solution when drug molecules interact with drug aims. New drug development discovers new molecules that interact with the aim in the body that usually functions abnormally when diseased.
By shooting a laser through a sample and measuring how the light scatters after passing through it, MSI can determine molecular binding between a new drug candidate and the target molecule. Dr.
We are working towards accelerating drug development projects by providing the best technology to characterize drug interactions with complex targets quickly and cost effectively , says
Most Popular Stories
- 2016 Camaro Shrinks, Moves to Caddy Platform
- Eric Garcia Appointed as Revenue Chief
- Tablets, Cars Drive AT&T Gains
- More Hispanic Voters May Not Mean More Clout
- New Effort to Ban Child Labor From Tobacco Farms
- Stocks Subdued After Gains Earlier in Week
- Apple Pay Debuts With Few Issues
- Government: 500 Million Records Stolen in 12 Months
- Pistorius Gets 5-year Sentence in Shooting Death
- Mom Makes Toys R Us Pull 'Breaking Bad' Dolls